Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1898 USD | -0.68% | +26.53% | -83.08% |
Financials (USD)
Sales 2024 * | 52.3M | Sales 2025 * | 56.45M | Capitalization | 6.17M |
---|---|---|---|---|---|
Net income 2024 * | -9M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.12 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.11 x |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-1.73
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on BIOLASE, Inc.
1 day | -0.68% | ||
1 week | +26.53% | ||
Current month | +37.54% | ||
1 month | +37.04% | ||
3 months | -84.31% | ||
6 months | -89.46% | ||
Current year | -83.08% |
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.1898 | -0.68% | 5,944,203 |
24-03-27 | 0.1911 | +19.21% | 10,108,691 |
24-03-26 | 0.1603 | -5.71% | 3,803,743 |
24-03-25 | 0.17 | -5.19% | 9,181,396 |
24-03-22 | 0.1793 | +19.53% | 131,373,307 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.08% | 6.17M | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |